EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Sentinel node biopsy and survival in cutaneous melanoma: a nationwide population-based cohort study

Marie B Weitemeyer, Neel M Helvind, Caroline A Gjorup, Frank Eriksson, Pernille Bidstrup, Karina D Steffensen, Adam Andrzej Luczak, Lars Bastholt, Henrik Schmidt, Inge Marie Svane, Eva Ellebaek, Lisbet R Hölmich

European Journal of Surgical Oncology · 2026-10 · 52 (10) · 112052

DOI: 10.1016/j.ejso.2026.112052 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Surgical Oncology, 2026-10. Verfasst von Marie B Weitemeyer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark. Electronic address: marie.br…. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Melanoma, Skin Neoplasms. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Cancer Society, Grocer M Kristjan Kjær and Wife Margrethe Kjær Born la Cour-Holmes Fund, Danish Cancer Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The therapeutic benefit of sentinel node biopsy (SNB) for melanoma patients remains controversial. We aimed to evaluate the association between SNB and survival outcomes in a nationwide population-based Danish cohort. MATERIALS AND METHODS: This retrospective cohort study included patients diagnosed with cutaneous melanoma between 2010 and 2017 who were candidates for SNB according to contemporary national guidelines. Augmented inverse probability of treatment weighting (AIPTW) was used to estimate standardized absolute risks and risk differences (RD) for 5-year overall survival, melanoma-specific mortality, other-cause mortality, and recurrence outcomes under two hypothetical strategies: all patients undergoing SNB versus no patients undergoing SNB. RESULTS: Of 6952 eligible patients, 5679 (81.7%) underwent SNB. After AIPTW, the standardized 5-year overall survival was higher under the SNB strategy (82.5% vs 73.7%, RD -8.8 pp, 95% CI -12.0; -5.6), whereas there was no clear difference in melanoma-specific mortality between strategies (9.0% vs 9.8%, RD -0.8 pp, 95% CI -3.0; 1.5). Other-cause mortality was lower under the SNB strategy (8.5% vs 16.8%, RD -8.3 pp, 95% CI -11.1; -5.5). No difference was found for standardized 5-year risk of any recurrence (19.0% vs 18.9%; RD 0.1 pp, 95% CI -3.2; 3.4), nor for distant recurrence. Regional nodal recurrence was lower under the SNB strategy (4.6% vs 8.5%, RD -3.9 pp, 95% CI -6.3; -1.5). CONCLUSION: Since SNB cannot plausibly influence other-cause mortality, our findings indicate residual confounding despite robust adjusted analyses. Observational data such as ours cannot reliably determine whether SNB confers a therapeutic effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sentinel Lymph Node BiopsyMelanomaSkin NeoplasmsHumansFemaleDenmarkMaleRetrospective StudiesMiddle AgedAgedSurvival RateNeoplasm Recurrence, LocalCutaneous Malignant MelanomaAdultLymphatic MetastasisNeoplasm StagingAged, 80 and over

Stichwörter der Autor:innen

Cohort studyMelanomaMortalityRecurrenceSentinel lymph node biopsySurvival

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark. Electronic address: marie.brinch@hotmail.com.
  • Department of Plastic and Reconstructive Surgery, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Psychological Aspects of Cancer, Danish Cancer Society, Copenhagen, Denmark.
  • Faculty of Medicine, Aalborg University, Aalborg, Denmark.
  • Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.

Förderung

  • Danish Cancer Society
  • Grocer M Kristjan Kjær and Wife Margrethe Kjær Born la Cour-Holmes Fund
  • Danish Cancer Research Fund

Zitieren

APA

Weitemeyer, M. B., Helvind, N. M., Gjorup, C. A., Eriksson, F., Bidstrup, P., Steffensen, K. D., Luczak, A. A., Bastholt, L., Schmidt, H., Svane, I. M., Ellebaek, E., & Hölmich, L. R. (2026). Sentinel node biopsy and survival in cutaneous melanoma: a nationwide population-based cohort study. European Journal of Surgical Oncology, 52(10), 112052. https://doi.org/10.1016/j.ejso.2026.112052

Vancouver

Weitemeyer MB, Helvind NM, Gjorup CA, Eriksson F, Bidstrup P, Steffensen KD, et al. Sentinel node biopsy and survival in cutaneous melanoma: a nationwide population-based cohort study. European Journal of Surgical Oncology. 2026;52(10):112052. doi:10.1016/j.ejso.2026.112052

BibTeX
@article{Weitemeyer2026,
  author = {Weitemeyer, Marie B and Helvind, Neel M and Gjorup, Caroline A and Eriksson, Frank and Bidstrup, Pernille and Steffensen, Karina D and Luczak, Adam Andrzej and Bastholt, Lars and Schmidt, Henrik and Svane, Inge Marie and Ellebaek, Eva and Hölmich, Lisbet R},
  title = {Sentinel node biopsy and survival in cutaneous melanoma: a nationwide population-based cohort study},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {10},
  pages = {112052},
  doi = {10.1016/j.ejso.2026.112052}
}
Kostenlos starten →